Spatial control of EGF receptor activation by reversible dimerization on living cells
- PMID: 20208517
- DOI: 10.1038/nature08827
Spatial control of EGF receptor activation by reversible dimerization on living cells
Abstract
Epidermal growth factor receptor (EGFR) is a type I receptor tyrosine kinase, the deregulation of which has been implicated in a variety of human carcinomas. EGFR signalling is preceded by receptor dimerization, typically thought to result from a ligand-induced conformational change in the ectodomain that exposes a loop (dimerization arm) required for receptor association. Ligand binding may also trigger allosteric changes in the cytoplasmic domain of the receptor that is crucial for signalling. Despite these insights, ensemble-averaging approaches have not determined the precise mechanism of receptor activation in situ. Using quantum-dot-based optical tracking of single molecules combined with a novel time-dependent diffusivity analysis, here we present the dimerization dynamics of individual EGFRs on living cells. Before ligand addition, EGFRs spontaneously formed finite-lifetime dimers kinetically stabilized by their dimerization arms. The dimers were primed both for ligand binding and for signalling, such that after EGF addition they rapidly showed a very slow diffusivity state that correlated with activation. Although the kinetic stability of unliganded dimers was in principle sufficient for EGF-independent activation, ligand binding was still required for signalling. Interestingly, dimers were enriched in the cell periphery in an actin- and receptor-expression-dependent fashion, resulting in a peripheral enhancement of EGF-induced signalling that may enable polarized responses to growth factors.
Similar articles
-
Oligomerization-function relationship of EGFR on living cells detected by the coiled-coil labeling and FRET microscopy.Biochim Biophys Acta. 2015 Jun;1848(6):1359-66. doi: 10.1016/j.bbamem.2015.03.004. Epub 2015 Mar 11. Biochim Biophys Acta. 2015. PMID: 25771448
-
Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling.Mol Biol Cell. 2002 Jul;13(7):2547-57. doi: 10.1091/mbc.01-08-0411. Mol Biol Cell. 2002. PMID: 12134089 Free PMC article.
-
All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.J Cell Sci. 2008 Oct 1;121(Pt 19):3207-17. doi: 10.1242/jcs.033399. Epub 2008 Sep 9. J Cell Sci. 2008. PMID: 18782861
-
Epidermal growth factor receptor (EGFR) signaling in cancer.Gene. 2006 Jan 17;366(1):2-16. doi: 10.1016/j.gene.2005.10.018. Epub 2005 Dec 27. Gene. 2006. PMID: 16377102 Review.
-
The EGFR family: not so prototypical receptor tyrosine kinases.Cold Spring Harb Perspect Biol. 2014 Apr 1;6(4):a020768. doi: 10.1101/cshperspect.a020768. Cold Spring Harb Perspect Biol. 2014. PMID: 24691965 Free PMC article. Review.
Cited by
-
A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations.Nat Commun. 2022 Nov 14;13(1):6944. doi: 10.1038/s41467-022-34627-5. Nat Commun. 2022. PMID: 36376325 Free PMC article.
-
Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2-ErbB3 complex in their active conformations.J Mol Model. 2013 Feb;19(2):931-41. doi: 10.1007/s00894-012-1613-y. Epub 2012 Oct 23. J Mol Model. 2013. PMID: 23090500
-
Direct quantification of ligand-induced lipid and protein microdomains with distinctive signaling properties.ChemSystemsChem. 2022 Sep;4(5):e202200011. doi: 10.1002/syst.202200011. Epub 2022 Apr 26. ChemSystemsChem. 2022. PMID: 36337751 Free PMC article.
-
Dynamically varying interactions between heregulin and ErbB proteins detected by single-molecule analysis in living cells.Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):13984-9. doi: 10.1073/pnas.1200464109. Epub 2012 Aug 13. Proc Natl Acad Sci U S A. 2012. PMID: 22891299 Free PMC article.
-
Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.Br J Pharmacol. 2012 May;166(2):532-53. doi: 10.1111/j.1476-5381.2012.01873.x. Br J Pharmacol. 2012. PMID: 22289125 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous